Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss
A qualified provider will assess whether GLP-1 therapy aligns with the patient's clinical goals, risk tolerance, and ability to monitor for side effects
The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium
Studies show that, at the right dosage, oral semaglutide agonists are as effective as injectables
What GLP-1 skincare can do is to help improve skin quality, specifically its hydration levels, firmness, and smoothness
Ozempic Updates from 2020 through 2024 September 16, 2024: Blindness and Vision Loss Becoming A Growing Concern in the Ozempic Lawsuits The American Association of Ophthalmology suggests that Ozempic and other GLP-1 drugs increase the risk of cause blindness or vision loss in several ways